Brief: Verve Therapeutics Q4 EPS USD -0.58
Feb 27 (Reuters) - Verve Therapeutics Q4 collaboration revenue USD 13.08 million. Q4 net income USD -50.035 million
Feb 27 (Reuters) - Verve Therapeutics Q4 collaboration revenue USD 13.08 million. Q4 net income USD -50.035 million